Public | |
Traded as | NASDAQ: LFVN |
Industry | Multi-level marketing |
Founded | 2003 |
Headquarters | Salt Lake City, Utah, United States |
Area served
|
United States, Canada, Japan, Mexico, Australia, Hong Kong |
Key people
|
Darren Jensen President, CEO Robert M. Urban COO Mark Jaggi CFO Joe M. McCord Chief Science Officer (retired) |
Products | Dietary supplements, skin care |
Revenue | US$ 208.2 million (2013) |
US$ 12.1 million | |
Website | www |
Protandim is a patenteddietary supplement marketed by LifeVantage Corporation (NASDAQ: LFVN; formerly LifeLine Therapeutics, Lifeline Nutraceuticals, and Yaak River Resources, Inc), a Utah-based multi-level marketing company. The manufacturers of Protandim claim the product can indirectly increase antioxidant activity by upregulating endogenous antioxidant factors such as the enzymes superoxide dismutase (SOD) and catalase, as well as the tripeptide glutathione. Like all dietary supplements, Protandim has not been evaluated by the U.S. Food and Drug Administration (FDA) and "is not intended to diagnose, treat, cure, or prevent any disease." No published peer-review studies have ever shown it effective in humans. In 2017, LifeVantage was issued a warning letter by the U.S. Food and Drug Administration (FDA) regarding illegal advertising claims on the company’s websites suggesting that Protandim can play a role in helping to cure various ailments, including cancer and diabetes.
In 2003, Lifeline Therapeutics, a privately held Denver-based nutraceutical licensing and marketing company, entered into a agreement with Massachusetts biotechnology company CereMedix for the rights to market CMX-1152, an experimental peptide-based compound, under the brand name "Protandim" (also sometimes referred to at that time as "Rholen," "Rejuven8r" and "ependymin"). CereMedix was a ten percent owner of Lifeline and members of the CereMedix management board served on Lifeline’s board of directors. CMX-1152 was claimed to upregulate the production of the endogenous antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxidase, and to offset the ageing process.